High-Performance Separation-Electrospray Ionization System - - BioPharm International

ADVERTISEMENT

High-Performance Separation-Electrospray Ionization System


BioPharm International
Volume 27, Issue 4, pp. 40-42

AB Sciex introduces the CESI 8000 System for Biologics Characterization, a high-performance separation-electrospray ionization system for mass spectrometry. CESI combines capillary electrophoresis (CE) and electrospray ionization (CESI). This new front-end CESI technology from the company’s SCIEX Separations business can be integrated with the AB Sciex TripleTOF 5600+ MS system.

The CESI 8000 provides improved results compared to dual-method liquid chromatography/mass spectrometry-based approaches.  From a single digest and run, users of CESI-MS gain identity and purity information with 100% coverage in a peptide map, heterogeneity information with ultrasensitive glycopeptide quantitation, and stability information identifying, deamidation, cyclization, and oxidation.

According to the company, CESI technology is designed to improve biophysicochemical characterization and guide the development of biologics-based therapeutics.  Specifically, CESI-MS serves to improve ionization efficiency and reduce ion suppression.

AB Sciexa

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

First Biosimilar Application Kicks Off Legal Battle
October 31, 2014
FDA Approves Pfizer's Trumenba for the Prevention of Meningitis B
October 30, 2014
EMA: Extrapolation Across Indications for Biosimilars a Possibility
October 30, 2014
Bristol-Myers Squibb Announces Agreement to Acquire HER2-Targeted Cancer Treatment
October 29, 2014
Amgen, Sanofi, and Ono Pharmaceuticals Partner with Universities on Transmembrane Protein Research
October 28, 2014
Author Guidelines
Source: BioPharm International,
Click here